News

2
Jul

PROTOCOL – Subcutaneous Injection

ProtocolSubcutaneous InjectionPlease fill in the form below to access our poster. After submitting this form, you will receive an email containing the link to access our poster. We'd like you to know that we take data confidentiality very seriously. The information you enter in this form will only be collected and processed to answer your request and facilitate our mutual
Read more
2
Jul

PROTOCOL – Intradermal Injection

ProtocolIntradermal InjectionPlease fill in the form below to access our poster. After submitting this form, you will receive an email containing the link to access our poster. Need more info? Please contact us! Contact us
16
May

Injection site reactions platform

Assessment of injection site reactionsA new proprietary research tool to identify drug-related immune adverse reactions in human skinToday, biologics represent one of the fastest growing markets within the pharmaceutical industry.The pipeline of biological drugs is growing at a rapid pace with a global market expected to reach over 460 billion USD in 2024 (1). In order to bypass gastric metabolism,
Read more
17
Apr

Genoskin at the European Mast Cell and Basophil Research Network meeting

Genoskin at the European Mast Cell and Basophil Research Network meeting in ToulouseAdvancing mast cell research through in vitro evaluation of mast cell responsesWe were thrilled to participate in the prestigious European Mast cell and Basophil Research Network (EMBRN) Conference, which took place in Genoskin’s hometown, Toulouse, France, from May 29-31, 2024. This event brought together prominent academic researchers, clinicians,
Read more
15
Apr

Mast Cells: Can’t live with them, can’t live without them? – Webinar Q&A

Thank you for your interest in our webinar on the dual role of mast cells, titled "Mast Cells: Can't live with them, can't live without them?". Below, you will find the questions we did not have time to address during the live session with Dr. Marcus Maurer. Q: In cold activated urticaria, is some of it caused by clonotypic IgE which
Read more
18
Mar

Genoskin at the World Vaccine Congress in DC!

Genoskin at the World Vaccine CongressAdvancing Vaccine Research with High-Dimensional Immune ProfilingFrom April 1-4, 2024, the global vaccine community gathered for the World Vaccine Congress in Washington, D.C. Taking place at the heart of the nation's capital, the congress was a cornerstone event for vaccine professionals worldwide, offering a platform for sharing groundbreaking research, fostering collaborations, and exploring the latest
Read more